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Abstract
Background: Latent Female Genital tuberculosis (FGTB) or tubercular infestation
is prevalent in Southeast Asia and even the presence of tubercular bacilli in the
genital tract is becoming an important factor for reproductive failure. An imma-
ture endometrium becomes non-receptive, preventing implantation or rejection of
implanted embryo in early months, resulting in recurrent pregnancy loss (RPL) in
association with other factors.
Objective: To detect the underlying causes of RPL in addition to the proven causes like
uterine cavity defects, thrombophilia, chromosomal abnormalities, etc.
Materials and Methods: 317 women with RPL, enrolled over a period of 60 months
( January 2014 to December 2018) conducted at Calcutta Fertility Mission in the present
study. Theywere grouped in A, B, andC and undergone routine tests for the same along
with the PCR test with an endometrial aspirate.
Results: Patients with only latent FGTB (Group A), patients with FGTB and associated
factors (Group B), and patients with other causes of RPL (other than latent FGTB) (Group
C) were34.4%, 42.3%, and 23.3% respectively. About 29.36%, 47.01%, and 21.62%of
the patients had achieved pregnancy in Group A, B, and C, respectively. The rate of
miscarriage was high in both Groups A and B, affected with latent FGTB, and live-birth
was higher (75%) in Group C that did not have tubercular involvement of the genital
tract.
Conclusion: The tubercular infestation or latent FGTB as per our study appears to be
a very important cause of RPL in patients with recurrent “unexplained” miscarriage. It
should be treated adequately at an early stage to prevent permanent damage to pelvic
organs and restore reproductive health in women.
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1. Introduction
Female genital tuberculosis (GTB) is typically
detected in 18-19% of Indian women of the repro-
ductive age groups as per a study conducted
in 2008, which increased to 19-30% in 2015,
affecting the pelvic organs by different routes,
often during investigating for infertility (1). It is
difficult to find out the actual incidence of GTB
as many cases are asymptomatic and diagnosed
incidentally. Although the frank Extra-pulmonary
tuberculosis (EPTB) in the form of GTB is prevalent
in Southeast Asia, the mere presence of tubercular
bacilli in the genital tract which may otherwise
be called as latent female genital tuberculosis
(FGTB)infestation is becoming more and more
important as a causative factor for reproductive
failure (2, 3). Implantation is one of the impor-
tant early stages for the initiation of successful
pregnancy that involves formation of matured
embryo and receptive endometrium. An immature
endometrium becomes non-receptive that does
not allow implantation and rejects the implanted
early embryo from its nidation site. Endometrial
development may be affected by tubercular infes-
tation that invites harmful cytokines in the decidua.
It has been observed that sub-endometrial vas-
cularity decreases due to the involvement of
basal layer of the endometrium in latent FGTB
as evident by pioneer work (4). The possibility
of vascular micro thrombus formation following
the tubercular assault of endometrium leads to
implantation failure and miscarriage. Tuberculous
endometritis is found in 80% of patients, whereas
tuberculous salpingitis and oophoritis are seen in
around 8% of them (5, 6). However, according
to few, the endometrium appears to be the most
commonly involved site in EPTB (7). The incidence
of pregnancy and live birth following is seen to be
quite low and the possibility of ectopic pregnancy
increases or results in loss of pregnancy (8, 9).
The purpose of this study was to detect the
underlying causes of recurrent pregnancy loss
(RPL) in addition to the causes like uterine cavity
defects, thrombophilia, chromosomal abnormali-
ties, etc., so far mentioned in literature.
2. Materials and Methods
A total of 317 woman aged range between 20-45
yr old who were referred to Department of Repro-
ductive Medicine at Calcutta Fertility Mission, over
a period of 60 months ( January 2014 to December
2018) were enrolled in this observational study.
The inclusion criteria were woman who had two or
more recurrent pregnancy losses, women who had
diagnosed uterine malformations, chromosomal
defects, thrombophilia etc. were excluded.
Women were divided into three groups: Groups
A, B, and C in which Group A (only TB-PCR Positive,
n = 109) included patients with RPL who had
only latent FGT Bas the etiological factor of the
losses among the factors screened in this study.
Group B (TB-PCR Positive, n = 134) consisted of
women with recurrent miscarriage who were found
to have tubercular bacilli alongwith any of the other
factors as etiology. Group C (TB-PCR-Negative,
n = 74) included patients who did not have any
tubercular infestation but some other etiology for
RPL. They had undergone routine tests for the
same along with the PCR test with an endometrial
aspirate.
2.1. Ethical consideration
The Ethical Committee of Calcutta Fertility Mis-
sion has given clearance for the retrospective
study of a prospective database on 02/01/2019
(code: CFM/2019/024). Written informed consent
has been obtained from all women who partici-
pated in the study.
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2.2. Statistical analysis
The obtained results were analyzed using SPSS
Statistics software (Statistical Package for the
Social Sciences, version 17.0, SPSS Inc, Chicago,
Illinois, USA). The comparison between groups
was evaluated using the Pearson’s Chi-Square
test and Fischer’s exact test. A P value of
<0.05 was considered to be statistically signifi-
cant.
3. Results
A total of 317 patients included in this study
were divided into three groups as follows: Group
A consisted of 109 patients (34.4%), Group B
included 134 patients (42.3%), and Group C had
74 patients (23.3%). Both the age of the patient
and their obstetric score did not have any sta-
tistical significance in the present study. 76.6%
had latent FGTB detected by PCR test (TB-PCR
positive). On a descriptive statistical analysis,
it was observed that the latent FGTB was an
important cause of RPL irrespective of associ-
ation with the other etiological factors, age, or
the obstetric score (Tables I, II). Other causes of
RPL like overt diabetes, hypothyroidism or hyper-
thyroidism, hyperandrogenism, hyperprolactine-
mia, low ovarian reserve, hyperhomocysteinemia,
antiphospholipid antibody syndrome, and toxo-
plasmosis were analyzed (Table III).
Both impaired Glucose Tolerance Test and
abnormal levels of TSH were not seen to be a
statistically significant cause of RPL (p = 0.618).
Though we found that the patients suffering from
RPL have increased testosterone or decreased
AMH levels with or without associated latent FGTB,
these parameters were not statistically significant
(p = 0.377). Even increased levels of Serum Homo-
cysteine was not found to have any statistical (p =
0.496).
Group C participants who had hyperprolactine-
mia as the only etiology of RPL were more than
the participants of Group B who had increased
levels of prolactin associated with latent FGTB. In
both groups, B and C, toxoplasmosis was seen
to be a statistically significant factor for causing
RPL. Anti-cardiolipin antibodies and Lupus anti-
coagulant time also did not have any statistical
significance as the RPL etiology. Among these
three groups the clinical pregnancy rate (CPR),
live birth rate (LBR), and miscarriage rate have
been calculated and compared. CPR within next
12 months, after taking anti-tubercular drugs for six
months, was more in Group B when compared to
Groups A and C and was statistically significant.
Also, LBR and miscarriage rate was statistically
significant (Table IV). The rate of miscarriage
was high in both Groups A and B compared to
Group C.
Table I. Age of women in groups
Age Group Total P-value
Group A Group B Group C
20-25 27 (24.77) 16 (11.94) 17 (22.97) 60 (18.93)
26-30 40 (36.7) 59 (44.03) 19 (25.68) 118 (37.22)
31-35 29 (26.61) 37 (27.61) 25 (33.78) 91 (28.71)
36-40 9 (8.26) 19 (14.18) 12 (16.22) 40 (12.62)
41-45 4 (3.67) 3 (2.24) 1 (1.35) 8 (2.52)
0.060
Data presented as n (%); Pearson’s Chi-Square test
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Table II. Obstetric score of participants
Obstetric score Group Total P-value
Group A Group B Group C
P (0+2) 23 (21.1) 43 (32.09) 29 (39.19) 95 (29.97)
P (0+3) 60 (55.05) 59 (44.03) 27 (36.49) 146 (46.06)
P (0+4) 11 (10.09) 13 (9.7) 5 (6.76) 29 (9.15)
P (0+5) 2 (1.83) 9 (6.72) 1 (1.35) 12 (3.79)
P (0+6) 4 (3.67) 1 (0.75) 1 (1.35) 6 (1.89)
P (0+7) 1 (0.92) 1 (0.75) 3 (4.05) 5 (1.58)
P (1+2) 3 (2.75) 3 (2.24) 3 (4.05) 9 (2.84)
P (1+3) 2 (1.83) 4 (2.99) 2 (2.7) 8 (2.52)
P (1+4) 3 (2.75) 0 (0) 1 (1.35) 4 (1.26)
P (2+2) 0 (0) 1 (0.75) 2 (2.7) 3 (0.95)
0.064
Data presented as n (%); Pearson’s Chi-Square test, P: Parity
Table III. Participants etiology
Group A Group B Group C P-value
Pcr/Mtb 109 (100) 134 (100) 0 (0) <0.001
Gtt 0 (0) 42 (31.34) 14 (18.92) 0.053
Tsh 0 (0) 20 (14.93) 13 (17.57) 0.618
Toxo 0 (0) 4 (2.99) 12 (16.22) 0.001
Aca 0 (0) 9 (6.72) 3 (4.05) 0.545
La 0 (0) 5 (3.73) 5 (6.76) 0.339
St 0 (0) 32 (23.88) 16 (21.62) 0.711
Amh 0 (0) 34 (25.37) 23 (31.08) 0.377
Prl 0 (0) 15 (11.19) 20 (27.03) 0.003
Homocysteine 0 (0) 7 (5.22) 2 (2.7) 0.496
Data presented as n (%); Fischer’s exact test
PCR/MTB: Polymerase chain reaction/ mycobacterium tuberculosis; GTT: Glucose tolerance test; TSH: Thyroid stimulating
hormone; TOXO: Toxoplasmosis; ACA: Anti-cardiolipin antibody; LA: Lupus anticoagulant; ST: Serum testosterone; AMH:
Anti-Mullerian hormone; PRL: Prolactin
Table IV. Clinical pregnancy rate, live birth rate, and miscarriage rate in groups
Group A Group B Group C Total P-value
Clinical pregnancy 32 (29.36) 63 (47.01) 16 (21.62) 111 (35.02) <0.001
Live birth 12 (37.5) 22 (34.92) 12 (75) 46 (41.44) 0.013
Miscarriage 20 (62.5) 39 (61.9) 3 (18.75) 62 (55.86) 0.005
Data presented as n (%); Pearson’s Chi-Square test
4. Discussion
Repeated miscarriage appears to be a curse in a
woman’s reproductive career. It becomes difficult
to form a work-up to detect the cause of RPL
in the early months as a continuation of preg-
nancy involves many factors. The factors may be
genetic factors, anatomical causes (uterine cavity
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defect), hormonal causes, or miscellaneous like
infections and immunological factors. In this study,
uterine defects and ectopic pregnancy have been
excluded, and a focus is placed on other factors.
Routine tests which involve factors mentioned
previously have been performed in all patients
and one new test included in the miscellaneous
group has been performed to detect a tubercular
infestation of the endometrium as a causative
factor of RPL (10). It has been observed that quite
a large number of cases of RPL are affected
with latent FGTB or a tubercular infestation of
the endometrium as a sole or strongly associated
factor for the development of such an unfortunate
situation.
The prevalence of FGTB in developing countries
is high among infertile patients with tubal factor
involvement, involving almost 90%; with 82.9%
having endometrial involvement too (11).
It has been seen that 92.3% of infertile women
without tubal defects who had been treated with
anti-tubercular drugs (ATD) based on a positive
endometrial aspirate TB-PCR test had spontaneous
conception within 12 months of treatment (12).
Similarly, in our study, patients with RPL with
secondary infertility who otherwise had no other
demonstrable cause of pregnancy loss other than
latent FGTB, 29.36% of patients had conceived
spontaneously during or within 12 months of ATD
administration. 47.01% of the patients in our study
had spontaneous conception after a treatment with
ATD and any other associated etiological factor
for RPL. Anti-tubercular treatment (ATT) should be
given in early disease if the patient had raised
ESR (≥ 20 mm/first hr), Mantoux test positive
(induration ≥ 10 mm), hysterosalpingography pic-
ture or ultrasonological picture suggestive of GTB.
Hence the chances of pregnancy can be enhanced
and irreversible damage to the endometrium and
especially fallopian tubes can be prevented and
there will be increased chances of conception (13).
In our study, 16.22% of patients had toxoplas-
mosis as the sole factor for RPL, whereas 2.99
% of them had toxoplasmosis associated with
latent FGTB, which complies with other studies (14,
15). Hyperprolactinemia in initial stage of follicu-
lar growth may hinder secretion of progesterone
which eventually result in luteal phase defects and
RPL, and the treatment may reduce the rate of
miscarriage in a subsequent pregnancy in these
women which is similar to our findings (16).
In recent studies, only 36.7% patients with GTB
have been noted to achieve pregnancy after ATD
treatment which concludes that the outcome of
infertility in GTB is not very optimistic and IVF-ET
need to be considered in such cases (8). In this
study, CPR and LBR were relatively better being
29.36% and 37.5%, respectively, in Group A and
47.01% and 34.92%, respectively, in Group B.
In our study, the rate of miscarriage in an
ongoing pregnancy was high in both Group A
(62.5%) and Group B (61.9%); compared to 18.75% in
GroupC that correlates with other studies (17) which
conclude that in women with GTB, the CPR per
cycle was low and spontaneous abortion was high.
Women with GTB were seen to represent a less
favorable group within other tubal factor patients
when treated with IVF-ET.
Low-grade inflammation might lead to minimal
structural and functional alteration of the pelvic
organs as observed in Mycobacterium tubercu-
losis infestation. Mycobacterium colonization in
the endometrium, what has been mentioned as
the tubercular infestation, may be a cause of
reproductive failure too (3). An important cause of
implantation failure is the immunological factor and
improving endometrial receptivity in the course of
fertility management by improving success rates.
The evaluation of implantation markers is neces-
sary to detect occult endometrial assault. The most
offensive cytokine for the loss of pregnancy is
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TNF-α. TNF-α, and anti-cardiolipin antibody levels
are seen to be potential diagnostic markers and
they exhibit significant role in prognosis of RPL
patients (18). An increased prevalence of IFN-γ
has been shown in endometrial aspirate in TBPCR
positive cases. Hence, IFNγ showed a possibility to
become an important clinical indicator of endome-
trial hostility followed by IL2 and on treatment by
ATD improved reproductive outcome indicating the
ill effect is reversible, as in contrast to tubercular
infection (3). Key endometrial genes expression
along with gene or stem cell-based therapies
may be incorporated to improve implantation (19).
Tubercular infestation or LGTB as per our study
appears to be a very important cause in patients
with apparently unexplained RPL following routine
tests. It appears that the exclusion of tubercular
infestation should be one of the most relevant
investigations in cases of RPL.
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